Chemotherapy Drug Market

Global Chemotherapy Drug Market Size, Share & Trends Analysis Report, By Types (Alkylating Agents, Antitumor Antibiotics, Plant Alkaloids, Antimetabolites, Topoisomerase Inhibitors, Miscellaneous Antineoplastic), By Route Of Administration (Intravenous, Oral, Intramuscular, Subcutaneous), By Distributional Channel (Hospitals, Ambulatory Surgical Centers, Clinics, Others) Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025268 | Category : Pharmaceuticals | Delivery Format: /

The global chemotherapy drug market is anticipated to grow at a significant CAGR  during the forecast period (2021-2027). Anticancer or chemotherapy drugs are chemicals that can denature cancer cells by arresting their growth. Though anticancer drugs affect the division of cancer cells, normal cells are also affected in the course of the event.

The growth of the cancer drugs market is driven by an increase in the prevalence of cancer disease and rise in the incidence of various cancer conditions, an increase in popularity of advanced therapies (biological and targeted drug therapies), and a surge in the geriatric population globally. In addition, the rise in cancer awareness, early screening of cancer also contribute toward the growth of the global chemotherapy drug market. However, the high cost involved in new drug development coupled with the threat of failure & adverse effects associated with cancer drugs therapies poses to restrain the growth of the global chemotherapy drugs market. Conversely, the high potential of emerging economies and the higher number of potential drugs in the pipeline are expected to offer lucrative opportunities during the forecast period.

Some key players operating in the market include Novartis AG, Amgen Inc., F. Hoffmann-La Roche Ltd, Sanofi, Eli Lilly and Company, among others. These players are aiming to strengthen their position in the market by adopting various strategies as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape:  Novartis AG, Amgen Inc., F. Hoffmann-La Roche Ltd, Sanofi, Eli Lilly and Company, among others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Chemotherapy Drug Market by Segments

By Types 

Alkylating Agents

Antitumor Antibiotics

Plant Alkaloids

Antimetabolites

Topoisomerase Inhibitors

Miscellaneous Antineoplastic

By Route Of Administration

Intravenous

Oral

Intramuscular

Subcutaneous

By Distributional Channel 

Hospitals

Ambulatory Surgical Centers

Clinics

Others

Global Chemotherapy Drug Market by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World